New video presentation published to strengthen work with marketing and sales. The video is part of a larger marketing package that has been developed in accordance with the strategy that the company presented with objectives to reach sales of about 20 million in 2020. The strategy’s focus is to launch BERA 3.0 in the spring
PhD student at the child and adolescent psychiatry at the University of Lund and chief physician Emma Claesdotter, defended on Friday her thesis “Auditory Brainstem Response (ABR) and Cambridge Neurophysiological Test Automated Battery (CANTAB) as Objective Support in Diagnosing Childhood ADHD and ASD”. Claesdotter has examined children and adolescents with ADHD and ASD with SensoDetect
Patent- System and method for improved determination of a brain response state in Australia has now been granted and SensoDetect have achieved the registrings- and approvalpapers via the patent attorney AWA patent. The patent is valid until 2037. For further reading go to AktieTorget.
SensoDetect is discussing a collaboration with one of Bolivia’s major distributors. The distributor has contacted SensoDetect regarding cooperation during last year and a first meeting and presentation took place at the beginning of the year in Bolivia. After dialogue during the spring and summer the distributor will now visit Sweden for further talks. For